MOLECULAR MECHANISMS REGULATING CD19, CD20 AND CD22 GENE-EXPRESSION

被引：71
|
作者：
KEHRL, JH
RIVA, A
WILSON, GL
THEVENIN, C
机构：
[1] John H. Kehrl, Agostino Riva, Gaye Lynn Wilson and Claire Thévenin are in the Section of B Cell Molecular Immunology, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda
来源：
IMMUNOLOGY TODAY | 1994年 / 15卷 / 09期
关键词：
D O I：
10.1016/0167-5699(94)90273-9
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The CD19, CD20 and CD22 genes encode transmembrane proteins that are of vital importance to B-cell function. Similar to the immunoglobulin (Ig) genes, they are expressed in a lineage-specific and developmentally regulated manner. Here, John Kehrl and colleagues describe how an understanding of the transcriptional regulation of the CD19, CD20 and CD22 genes is leading to valuable insights into some of the important molecular events that occur in B-cell development and differentiation.
引用
收藏
页码：432 / 436
页数：5
相关论文
共 50 条
  • [31] Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22
    Bobbitt, KR
    Justement, LB
    JOURNAL OF IMMUNOLOGY, 2000, 165 (10): : 5588 - 5596
  • [32] CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes
    Zhou, Q.
    Kneissl, S.
    Schwenkert, M.
    Cosset, F.
    Verhoeyen, E.
    Buchholz, C. J.
    HUMAN GENE THERAPY, 2013, 24 (12) : A87 - A87
  • [33] Diagnostic Utility of CD19 and CD22 Immunohistochemistry in the Diagnosis of Hodgkin and Large B Cell Lymphomas
    Mason, Emily F.
    Pinkus, Geraldine
    LABORATORY INVESTIGATION, 2017, 97 : 363A - 363A
  • [34] CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
    Kneissl, Sabrina
    Zhou, Qi
    Schwenkert, Michael
    Cosset, Francois-Loic
    Verhoeyen, Els
    Buchholz, Christian J.
    PLOS ONE, 2013, 8 (11):
  • [35] Diagnostic Utility of CD19 and CD22 Immunohistochemistry in the Diagnosis of Hodgkin and Large B Cell Lymphomas
    Mason, Emily F.
    Pinkus, Geraldine
    MODERN PATHOLOGY, 2017, 30 : 363A - 363A
  • [36] Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop
    Fujimoto, M
    Bradney, AP
    Poe, JC
    Steeber, DA
    Tedder, TF
    IMMUNITY, 1999, 11 (02) : 191 - 200
  • [37] Expression of CD19 and CD20 in plasma cells are significantly different between Han and Uygur multiple myeloma patients
    Cui, Yanjie
    Zhang, Fengbo
    Jiang, Ming
    Pang, Nannan
    Li, Zhi Wei
    Zhu, Yuejie
    Qu, Jianhua
    Ding, Jianbing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 13041 - 13046
  • [38] Peripheral T-Cell Lymphoma with Aberrant Expression of CD19, CD20, and CD79a: Case Report and Literature Review
    Matnani, Rahul G.
    Stewart, Rachel L.
    Pulliam, Joseph
    Jennings, Chester D.
    Kesler, Melissa
    CASE REPORTS IN HEMATOLOGY, 2013, 2013
  • [39] Semi-Quantitative Analysis of CD19 and CD22 Expression in B-Lymphoblastic Leukemia and Implications for Targerted Immunotherapy
    Rosenthal, Jaclyn
    Naqvi, Ammar S.
    Wertheim, Gerald
    Paessler, Michele
    Rheingold, Susan R.
    Thomas-Tikhonenko, Andrei
    Pillai, Vinodh
    BLOOD, 2017, 130
  • [40] Resistance to CD19 Immunotherapy in B-Cell ALL Is Associated with Loss of CD19 and CD22 and an Enhanced Vulnerability to B Cell Receptor Signaling Inhibition
    Aminov, Sarah
    Giricz, Orsi
    Sica, R. Alejandro
    Polishchuk, Veronika
    Yates, Bonnie
    Wang, Hao-Wei
    Wang, Yanhua
    Sahu, Srabani
    Gordon, Shanisha
    Schinke, Carolina
    Pradhan, Kith
    Aluri, Srinivas
    Janakiram, Murali
    Barta, Stefan K.
    Agarwal, Beamon
    Goldfinger, Mendel
    Shastri, Aditi
    Matsui, William
    Steidl, Ulrich
    Brody, Joshua
    Shah, Nirali N.
    Parekh, Samir
    Verma, Amit
    BLOOD, 2022, 140 : 3480 - 3481
12345